Cervomed to participate in upcoming investor conferences

Boston, march 28, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that company's management will participate in the following three investor conferences during the month of april:
CRVO Ratings Summary
CRVO Quant Ranking